Is Dexscanner 22A Safe?

Is Dexscanner 22A safe?

NO — USE WITH CAUTION — Dexscanner 22A has a Nerq Trust Score of 37.0/100 (E). It has below-average trust signals with significant gaps in security, maintenance, or documentation. Not recommended for production use without thorough manual review and additional security measures.

What Is Dexscanner 22A?

Dexscanner 22A is a software tool in the finance category: Monitors DEX spreads and executes arbitrage when profitable.. Nerq Trust Score: 37/100 (E).

Nerq independently analyzes every software tool, app, and extension across multiple trust signals including security vulnerabilities, maintenance activity, license compliance, and community adoption.

How Nerq Assesses Dexscanner 22A's Safety

Nerq's Trust Score is calculated from 13+ independent signals aggregated into five dimensions. Here is how Dexscanner 22A performs in each:

• Maintenance (0/100): Dexscanner 22A is potentially abandoned. We track commit frequency, release cadence, issue response times, and PR merge rates.
• Documentation (0/100): Documentation quality is insufficient. This includes README completeness, API documentation, usage examples, and contribution guidelines.
• Community (0/100): Community adoption is limited. Based on GitHub stars, forks, download counts, and ecosystem integrations.

The overall Trust Score of 37.0/100 (E) reflects the weighted combination of these signals. This is below the Nerq Verified threshold of 70. We recommend additional due diligence before production deployment.

Who Should Use Dexscanner 22A?

Dexscanner 22A is designed for:

• Developers and teams working with finance tools
• Organizations evaluating AI tools for their stack
• Researchers exploring AI capabilities in this domain

Risk guidance: We recommend caution with Dexscanner 22A. The low trust score suggests potential risks in security, maintenance, or community support. Consider using a more established alternative for any production or sensitive workload.

How to Verify Dexscanner 22A's Safety Yourself

While Nerq provides automated trust analysis, we recommend these additional steps before adopting any software tool:

1. Check the source code — Review the repository security policy, open issues, and recent commits for signs of active maintenance.
2. Scan dependencies — Use tools like npm audit, pip-audit, or snyk to check for known vulnerabilities in Dexscanner 22A's dependency tree.
3. Review permissions — Understand what access Dexscanner 22A requires. Software tools should follow the principle of least privilege.
4. Test in isolation — Run Dexscanner 22A in a sandboxed environment before granting access to production data or systems.
5. Monitor continuously — Use Nerq's API to set up automated trust checks: GET nerq.ai/v1/preflight?target=DexScanner-22A
6. Review the license — Confirm that Dexscanner 22A's license is compatible with your intended use case. Pay attention to restrictions on commercial use, redistribution, and derivative works. Some AI tools use dual licensing or have separate terms for enterprise customers that differ from the open-source license.
7. Check community signals — Look at the project's issue tracker, discussion forums, and social media presence. A healthy community actively reports bugs, contributes fixes, and discusses security concerns openly. Low community engagement may indicate limited peer review of the codebase.

Common Safety Concerns with Dexscanner 22A

When evaluating whether Dexscanner 22A is safe, consider these category-specific risks:

Best Practices for Using Dexscanner 22A Safely

Whether you're an individual developer or an enterprise team, these practices will help you get the most from Dexscanner 22A while minimizing risk:

When Should You Avoid Dexscanner 22A?

Even promising tools aren't right for every situation. Consider avoiding Dexscanner 22A in these scenarios:

• Production environments handling sensitive customer data
• Regulated industries (healthcare, finance, government) without additional compliance review
• Mission-critical systems where downtime has significant business impact

For each scenario, evaluate whether Dexscanner 22A's trust score of 37.0/100 meets your organization's risk tolerance. We recommend running a manual security assessment alongside the automated Nerq score.

How Dexscanner 22A Compares to Industry Standards

Nerq indexes over 6 million software tools, apps, and packages across dozens of categories. Among finance tools, the average Trust Score is 62/100. Dexscanner 22A's score of 37.0/100 is below the category average of 62/100.

This suggests that Dexscanner 22A trails behind many comparable finance tools. Organizations with strict security requirements should evaluate whether higher-scoring alternatives better meet their needs.

Industry benchmarks matter because they contextualize a tool's safety profile. A score that looks moderate in isolation may actually represent strong performance within a challenging category — or vice versa. Nerq's category-relative analysis helps teams make informed decisions by showing not just absolute quality, but how a tool ranks against its direct peers.

Trust Score History

Nerq continuously monitors Dexscanner 22A and recalculates its Trust Score as new data becomes available. Our scoring engine ingests real-time signals from source repositories, vulnerability databases (NVD, OSV.dev), package registries, and community metrics. When a new CVE is published, a major release ships, or maintenance patterns change, Dexscanner 22A's score is updated within 24 hours.

Historical trust trends reveal whether a tool is improving, stable, or declining over time. A tool that consistently maintains or improves its score demonstrates ongoing commitment to security and quality. Conversely, a downward trend may signal reduced maintenance, growing technical debt, or unresolved vulnerabilities. To track Dexscanner 22A's score over time, use the Nerq API: GET nerq.ai/v1/preflight?target=DexScanner-22A&include=history

Nerq retains trust score snapshots at regular intervals, enabling trend analysis across weeks and months. Enterprise users can access detailed historical reports showing how each dimension — security, maintenance, documentation, compliance, and community — has evolved independently, providing granular visibility into which aspects of Dexscanner 22A are strengthening or weakening over time.

Dexscanner 22A vs Alternatives

In the finance category, Dexscanner 22A scores 37.0/100. There are higher-scoring alternatives available. For a detailed comparison, see:

• Dexscanner 22A vs OpenBB — Trust Score: 64.7/100
• Dexscanner 22A vs qlib — Trust Score: 71.2/100
• Dexscanner 22A vs TradingAgents — Trust Score: 65.5/100

Key Takeaways

• Dexscanner 22A has a Trust Score of 37.0/100 (E) and is not yet Nerq Verified.
• Dexscanner 22A has significant trust gaps. Consider higher-rated alternatives unless specific requirements mandate its use.
• Among finance tools, Dexscanner 22A scores below the category average of 62/100, suggesting room for improvement relative to peers.
• Always verify safety independently — use Nerq's Preflight API for automated, up-to-date trust checks before integration.